Page last updated: 2024-08-16

pinacidil and omega-n-methylarginine

pinacidil has been researched along with omega-n-methylarginine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elliott, GT; Jacobson, KA; Liang, BT; Stambaugh, K1
Lerman, A; Mathew, V1
Di Girolamo, N; Heywood, GJ; Thomas, PS; Wei, XM1

Other Studies

3 other study(ies) available for pinacidil and omega-n-methylarginine

ArticleYear
Additive effects of late preconditioning produced by monophosphoryl lipid A and the early preconditioning mediated by adenosine receptors and KATP channel.
    Circulation, 1999, Jun-29, Volume: 99, Issue:25

    Topics: Adenosine; Animals; Cells, Cultured; Chick Embryo; Ischemic Preconditioning, Myocardial; Lipid A; Myocardium; omega-N-Methylarginine; Pinacidil; Potassium Channels; Purinergic P1 Receptor Agonists; Vasodilator Agents

1999
Altered effects of potassium channel modulation in the coronary circulation in experimental hypercholesterolemia.
    Atherosclerosis, 2001, Feb-01, Volume: 154, Issue:2

    Topics: Adenosine Triphosphatases; Animals; Blood Flow Velocity; Cation Transport Proteins; Cholesterol; Cholesterol, Dietary; Coronary Circulation; Coronary Vessels; Enzyme Inhibitors; Female; Glyburide; Hypercholesterolemia; Hypoglycemic Agents; Injections, Intra-Arterial; omega-N-Methylarginine; Pinacidil; Potassium Channels; Swine; Vasodilator Agents

2001
Nicorandil inhibits the release of TNFalpha from a lymphocyte cell line and peripheral blood lymphocytes.
    International immunopharmacology, 2003, Volume: 3, Issue:12

    Topics: B-Lymphocytes; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glyburide; Herpesvirus 4, Human; Humans; Immunoglobulin G; Leukocytes, Mononuclear; Niacinamide; Nicorandil; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Oxadiazoles; Pinacidil; Potassium Channels; Quinoxalines; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha

2003